Relationship between Central Insulin Resistance and Cerebrovascular Disease

doi:10.3969/j.issn.1673-5765.2022.11.020

Abstract

Abstract: Central insulin is involved in a variety of physiological functions of the brain and affects a variety of behaviors and metabolism. Central insulin resistance is defined as the inability of brain cells to respond to insulin. Central insulin resistance may be caused by down-regulation of insulin receptor expression, failure of insulin receptor to bind insulin, or incorrect activation of insulin signal cascade. There is a close relationship between central insulin resistance and cerebrovascular disease. Central insulin resistance can be assessed by hyperinsulinemic euglycemic clamp combined imaging technology, intranasal administration, ratio of serine phosphorylation to total phosphorylated insulin receptor substrates and determinating IRS-1 level and its phosphorylation status in neurogenic plasma exosomes. Exploring the relationship between central insulin resistance and cerebrovascular disease will help to provide new directions and targets for treatment of cerebrovascular diseases.

Key words: Insulin; Central insulin resistance; Cerebrovascular disease

摘要： 中枢胰岛素参与大脑的多种生理功能，对多种行为和代谢产生影响。中枢胰岛素抵抗的定义是脑细胞不能对胰岛素作出反应。胰岛素受体表达下调、胰岛素受体不能结合胰岛素以及胰岛素信号级联错误激活等原因都有可能导致中枢胰岛素抵抗。中枢胰岛素抵抗与脑血管病有着密切的关系。通过高胰岛素-正葡萄糖钳夹结合影像技术、经鼻给药、丝氨酸磷酸化与总磷酸化胰岛素受体底物比率和测定神经源性血浆外泌体中胰岛素受体底物1的水平及其磷酸化状态等方法可以对中枢胰岛素抵抗进行评估。探索中枢胰岛素抵抗机制与脑血管病的关系将有助于为脑血管病的治疗提供新的方向和靶点。

关键词: 胰岛素; 中枢胰岛素抵抗; 脑血管病

XU Zhichao, LI Runzhi, MI Donghua. Relationship between Central Insulin Resistance and Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2022, 17(11): 1276-1282.

胥智超, 李润芝, 米东华. 中枢胰岛素抵抗与脑血管病的关系[J]. 中国卒中杂志, 2022, 17(11): 1276-1282.

References

[1] 于瑶. 经鼻滴入胰岛素改善慢性脑缺血所致认知功能障碍的机制研究[D]. 长春：吉林大学，2021.
[2] 赵赛，李玉红，田兆方. 经鼻给予胰岛素样生长因子1对新生大鼠缺氧缺血性脑损伤的影响[J]. 中国临床康复，2005，9（13）：80-81.
[3] SHEN H C，GU X H，WEI Z Z，et al. Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice[J/OL]. Exp Neurol，2021，337：113542[2022-03-10]. https://doi.org/10.1016/j.expneurol.2020.113542.
[4] TU Y F，JIANG S T，CHOW Y H，et al. Insulin receptor substrate-1 activation mediated p53 downregulation protects against hypoxic-ischemia in the neonatal brain[J]. Mol Neurobiol，2016，53（6）：3658-3669.
[5] ARVANITAKIS Z，CAPUANO A W，WANG H Y，et al. Brain insulin signaling and cerebrovascular disease in human postmortem brain[J/OL]. Acta Neuropathol Commun，2021，9（1）：71[2022-03-10]. https://doi.org/10.1186/s40478-021-01176-9.
[6] KULLMANN S，HENI M，HALLSCHMID M，et al. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans[J]. Physiol Rev，2016，96（4）：1169-1209.
[7] DIEHL T，MULLINS R，KAPOGIANNIS D. Insulin resistance in Alzheimer's disease[J/OL]. Transl Res，2017，183：26-40[2022-03-10]. https://doi.org/10.1016/j.trsl.2016.12.005.
[8] GHASEMI R，DARGAHI L，HAERI A，et al. Brain insulin dysregulation：implication for neurological and neuropsychiatric disorders[J]. Mol Neurobiol，2013，47（3）：1045-1065.
[9] KULLMANN S，KLEINRIDDERS A，SMALL D M，et al. Central nervous pathways of insulin action in the control of metabolism and food intake[J]. Lancet Diabetes Endocrinol，2020，8（6）：524-534.
[10] BERLANGA-ACOSTA J，GUILLÉN-NIETO G，RODRÍGUEZ-RODRÍGUEZ N，et al. Insulin resistance at the crossroad of Alzheimer disease pathology：a review[J/OL]. Front Endocrinol（Lausanne），2020，11：560375[2022-03-10]. https://doi.org/10.3389/fendo.2020.560375.
[11] NETH B J，CRAFT S. Insulin resistance and Alzheimer's disease：bioenergetic linkages[J/OL]. Front Aging Neurosci，2017，9：345[2022-03-10]. https://doi.org/10.3389/fnagi.2017.00345.
[12] ARNOLD S E，ARVANITAKIS Z，MACAULEY-RAMBACH S L，et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease：concepts and conundrums[J]. Nat Rev Neurol，2018，14（3）：168-181.
[13] MIELKE R，HERHOLZ K，GROND M，et al. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type[J]. Neurobiol Aging，1992，13（1）：93-98.
[14] HOYER S，MÜLLER D，PLASCHKE K. Desensitization of brain insulin receptor effect on glucose/energy and related metabolism[J/OL]. J Neural Transm Suppl，1994，44：259-268[2022-03-10]. https://doi.org/10.1007/978-3-7091-9350-1_20.
[15] FRÖLICH L，BLUM-DEGEN D，BERNSTEIN H G，et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease[J]. J Neural Transm（Vienna），1998，105（4/5）：423-438.
[16] HOYER S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis[J]. J Neural Transm（Vienna），1998，105（4/5）：415-422.
[17] FELDMAN E L. Oxidative stress and diabetic neuropathy：a new understanding of an old problem[J]. J Clin Invest，2003，111（4）：431-433.
[18] KIM B，MCLEAN L L，PHILIP S S，et al. Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons[J]. Endocrinology，2011，152（10）：3638-3647.
[19] FERREIRA S T. Brain insulin，insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease[J/OL]. J Neuroendocrinol，2021，33（4）：e12959[2022-03-10]. https://doi.org/10.1111/jne.12959.
[20] YANG J J. Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology[J]. Acta Neurol Belg，2022，122（5）：1135-1142.
[21] 李焱. 中枢胰岛素抵抗与阿尔茨海默病发病关系的认识[J]. 诊断学理论与实践，2009，8（3）：248-251.
[22] DUTTA B J，SINGH S，SEKSARIA S，et al. Inside the diabetic brain：insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies[J/OL]. Pharmacol Res，2022，182：106358[2022-03-10]. https://doi.org/10.1016/j.phrs.2022.106358.
[23] AL HAJ AHMAD R M，ABABNEH N A，AL-DOMI H A. Brain insulin resistance as a mechanistic mediator links peripheral metabolic disorders with declining cognition[J/OL]. Diabetes Metab Syndr，2022，16（4）：102468[2022-03-10]. https://doi.org/10.1016/j.dsx.2022.102468.
[24] POMYTKIN I，PINEILS V. Brain insulin resistance：focus on insulin receptor-mitochondria interactions[J/OL]. Life（Basel），2021，11（3）：262[2022-03-10]. https://doi.org/10.3390/life11030262.
[25] TALBOT K，WANG H Y，KAZI H，et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance，IRS-1 dysregulation，and cognitive decline[J]. J Clin Invest，2012，122（4）：1316-1338.
[26] HUGHES T M，CRAFT S. The role of insulin in the vascular contributions to age-related dementia[J]. Biochim Biophys Acta，2016，1862（5）：983-991.
[27] KATAKAM P V，DOMOKI F，LENTI L，et al. Cerebrovascular responses to insulin in rats[J]. J Cereb Blood Flow Metab，2009，29（12）：1955-1967.
[28] VAN SLOTEN T T，SEDAGHAT S，CARNETHON M R，et al. Cerebral microvascular complications of type 2 diabetes：stroke，cognitive dysfunction，and depression[J]. Lancet Diabetes Endocrinol，2020，8（4）：325-336.
[29] ABNER E L，NELSON P T，KRYSCIO R J，et al. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology[J]. Alzheimers Dement，2016，12（8）：882-889.
[30] ARVANITAKIS Z，SCHNEIDER J A，WILSON R S，et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons[J]. Neurology，2006，67（11）：1960-1965.
[31] KELLAR D，CRAFT S. Brain insulin resistance in Alzheimer's disease and related disorders：mechanisms and therapeutic approaches[J]. Lancet Neurol，2020，19（9）：758-766.
[32] GHASEMI A，TOHIDI M，DERAKHSHAN A，et al. Cut-off points of homeostasis model assessment of insulin resistance，beta-cell function，and fasting serum insulin to identify future type 2 diabetes：tehran lipid and glucose study[J]. Acta Diabetol，2015，52（5）：905-915.
[33] KAPOGIANNIS D，BOXER A，SCHWARTZ J B，et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease[J]. FASEB J，2015，29（2）：589-596.